Dupilumab Treatment for Prurigo Nodularis and Pruritis
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment.
INTRODUCTION
Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni …
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment.
INTRODUCTION
Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni … Continue reading "Dupilumab Treatment for Prurigo Nodularis and Pruritis"
My Obsession with Cutaneous T-Cell Lymphoma (CTCL) – A Sneak Peek
In preparation for an exciting new Resident-led session at the upcoming ODAC conference, titled “My Obsession with CTCL”, I wanted to give you an overview of this broad category of diseases. I just remember my first Dermatology Grand Rounds presentation as a new resident was covering the topic of sarcoidosis. In this discussi … 